Home > Analytics > BLISS GVS PHARMA

BLISS GVS PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 506197     NSE : BLISSGVS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Aug 12,2022
Price(EOD): ₹ 76.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 795.63 Cr
Value of ₹ 1 Lac invested in BLISS GVS PHARMA
on Aug 14,2017 (price: ₹ 163.40)

₹ 1 L

₹ 0.47 L

1W : -2.9% 1M : 0.7% 1Y : -32%
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results
BLISS GVS PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA -2.9% 0.7% -32%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 6.2% 16%
DIVIS LABORATORIES -4.7% -1.3% -19.7%
DR REDDYS LABORATORIES 2.6% -5.4% -11%
CIPLA -0.7% 7.8% 13.8%
GLAND PHARMA 4.5% -3.4% -44.2%
PIRAMAL ENTERPRISES 11.2% 13.1% -31.4%
CADILA HEALTHCARE 8.3% 5.1% -33.9%
TORRENT PHARMACEUTICALS -1.1% 3.5% 1.4%

FUNDAMENTAL ANALYSIS OF BLISS GVS PHARMA

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BLISS GVS PHARMA

 
Valuation Score
[As on : Aug 12,2022 ]

Ratio Consolidated
P/E
P/B
P/S
52.86
P/E Calculated based on EPS of 1.45
[ Mar2022 - Consolidated Results ]

0.98
P/B Calculated based on Book Value of 78.01
[ Mar2022 - Consolidated Results ]

1.04
P/S Calculated based on Revenues of 767.97 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights 💡 BLISSGVS is one of the potential top 18% undervalued companies ! Discover More →

FAIR VALUE OF BLISS GVS PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-19%
-43%
-43%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BLISS GVS PHARMA



BLISS GVS PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BLISS GVS PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.1
0.12
0.13
0.12
0.13
0.15
0.16
0.15
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BLISS GVS PHARMA

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BLISS GVS PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
12.93%
92.67%
48.17%
17.1%
12.2%
12.28%
6.84%
5.15%
QtrlyTrend
8
Latest Qtr: Jun2022
Quarterly Result Analysis →


BLISS GVS PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP 1.7% 9.8% 8.8%
S&P BSE SMALL CAP 1.3% 8.2% 4.9%
S&P BSE MIDSMALLCAP 1.3% 8.7% 6.2%
S&P BSE HEALTHCARE -0.9% 4% -12.6%
No NSE index found

You may also like the below Video Courses


FAQ about BLISS GVS PHARMA


Is BLISS GVS PHARMA good for long term investment?

As on Aug 12,2022, the Fundamentals of BLISS GVS PHARMA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BLISS GVS PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BLISS GVS PHARMA UnderValued or OverValued?

As on Aug 12,2022, BLISS GVS PHARMA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BLISS GVS PHARMA ?

As on Aug 12,2022, the Intrinsic Value of BLISS GVS PHARMA is Rs. 135.04 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 95.18
Fair Value [Median EV / Sales Model] : Rs. 135.18
Fair Value [Median Price / Sales Model] : Rs. 135.04
Median Fair Value of BLISS GVS PHARMA : Rs. 135.04

Is BLISS GVS PHARMA trading at a Premium or Discount?

As on Aug 12,2022, BLISS GVS PHARMA is trading at a Discount of -43% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].